Publications by authors named "Jeremy Hayllar"

Claim this Profile
F
Factors Associated With Preferences for Opioid Agonist Therapies Among People Dependent on Opioids.
M J Stowe, Anna Conway, Frederick L Altice, Samantha College-Frisby, Phillip Read, Jeremy Hayllar

Drug Alcohol Rev· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Commentary on Metcalfe et al.: 'What works in AOD is when it feels like I am driving' (Craig W, alcohol and drug peer worker).
Jeremy S Hayllar

Addiction· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Australian retrospective observational cohort comparison of the use of long-acting injectable buprenorphine products.
Mark R C Daglish, Jeremy S Hayllar, Michael McDonough

J Subst Use Addict Treat· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors associated with experiencing stigma, discrimination, and negative health care treatment among people who inject drugs.
Timothy R Broady, Heather Valerio, Maryam Alavi, Alice Wheeler, David Silk, Jeremy Hayllar

Int J Drug Policy· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 3 randomised double-blind placebo-controlled trial of mirtazapine as a pharmacotherapy for methamphetamine use disorder: a study protocol for the Tina Trial.
Rebecca McKetin, Tayla J Degan, Lucy Saunders, Long Nguyen, Gregory Dore, Jeremy Hayllar

Trials· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytochrome P450-2D6 activity in people with codeine use disorder.
Mark R C Daglish, Sarah R Reilly, Sam Mostafa, Cameron Edwards, Thomas M O'Gorman, Jeremy S Hayllar

Pharmacogenomics J· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deimplementation in the provision of opioid agonist treatment to achieve equity of care for people engaged in treatment: a qualitative study.
Anna Conway, Alison D Marshall, Sione Crawford, Jeremy Hayllar, Jason Grebely

Implement Sci· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
'
'I just thought that was the best thing for me to do at this point': Exploring patient experiences with depot buprenorphine and their motivations to discontinue.
Simon Clay, Carla Treloar, Louisa Degenhardt, Jason Grebely, Michael Christmass, Jeremy Hayllar

Int J Drug Policy· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"You'll come in and dose even in a global pandemic": A qualitative study of adaptive opioid agonist treatment provision during the COVID-19 pandemic.
Anna Conway, Carla Treloar, Sione Crawford, Louisa Degenhardt, Gregory J Dore, Jeremy Hayllar

Int J Drug Policy· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kamini, a little recognised source of illicit opioid: A case series of 12 patients.
Tabibul Khan, Pem Ariyawansa, Janette Quinn, Jeremy Hayllar

Drug Alcohol Rev· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and factors associated with hospitalisation for bacterial skin infections among people who inject drugs: The ETHOS Engage Study.
Alice Wheeler, Heather Valerio, Evan B Cunningham, Marianne Martinello, Joshua A Barocas, Jeremy Hayllar

Drug Alcohol Depend· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs: The ETHOS Engage study.
Heather Valerio, Maryam Alavi, Anna Conway, David Silk, Carla Treloar, Jeremy Hayllar

Int J Drug Policy· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Testing Campaign Intervention Consisting of Peer-Facilitated Engagement, Point-of-Care HCV RNA Testing, and Linkage to Nursing Support to Enhance Hepatitis C Treatment Uptake among People Who Inject Drugs: The ETHOS Engage Study.
Anna Conway, Heather Valerio, Maryam Alavi, David Silk, Carla Treloar, Jeremy Hayllar

Viruses· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progress Towards Elimination of Hepatitis C Infection Among People Who Inject Drugs in Australia: The ETHOS Engage Study.
Heather Valerio, Maryam Alavi, David Silk, Carla Treloar, Marianne Martinello, Jeremy Hayllar

Clin Infect Dis· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis C virus testing, liver disease assessment and treatment uptake among people who inject drugs pre- and post-universal access to direct-acting antiviral treatment in Australia: The LiveRLife study.
Sahar Bajis, Jason Grebely, Behzad Hajarizadeh, Tanya Applegate, Alison D Marshall, Jeremy Hayllar

J Viral Hepat· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acceptability and preferences of point-of-care finger-stick whole-blood and venepuncture hepatitis C virus testing among people who inject drugs in Australia.
Sahar Bajis, Lisa Maher, Carla Treloar, Behzad Hajarizadeh, Francois M J Lamoury, Jeremy Hayllar

Int J Drug Policy· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the Xpert HCV Viral Load Finger-Stick Point-of-Care Assay.
Francois M J Lamoury, Sahar Bajis, Behzad Hajarizadeh, Alison D Marshall, Marianne Martinello, Jeremy Hayllar

J Infect Dis· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An overview of take-home naloxone programs in Australia.
Robyn Dwyer, Anna Olsen, Carrie Fowlie, Chris Gough, Ingrid van Beek, Jeremy Hayllar

Drug Alcohol Rev· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
General practitioner attitudes to prescribing hepatitis C antiviral therapy in a community setting.
Stephen M Lambert, Andrew N Page, Johannes Wittmann, Jeremy S Hayllar, Clint W Ferndale

Aust J Prim Health· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis